Hrt Financial »

Inhibikase Therapeutics shares owned by Hrt Financial

Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Hrt Financial from 13F filings

Historical chart of Hrt Financial investment in Inhibikase Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Inhibikase Therapeutics held by Hrt Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibikase Therapeutics by Hrt Financial

Quarter filed Position value Share count Share price at filing
2025-12-31 $21k 11k 1.99
2025-03-31 $144k 66k 2.18
2024-12-31 $150k 46k 3.23